Hargreaves Lansdown

Cambridge Cognition ex-CEO resigns as director

Fri 18 October 2024 11:40 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Cambridge Cognition, a provider of digital solutions for assessing brain health, announced the formal resignation of Dr Matthew Stork as a director of the company and its subsidiaries on Friday.

The AIM-traded firm said the move followed the earlier announcement on 12 September that Dr Stork had stepped down as chief executive officer.

It said his resignation meant the end of his directorship across all entities within the group.

At 1104 BST, shares in Cambridge Cognition were flat at 28p.

Reporting by Josh White for Sharecast.com.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found